125 related articles for article (PubMed ID: 15206988)
1. Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers.
Sobue S; Tan K; Layton G; Eve M; Sanderson JB
Br J Clin Pharmacol; 2004 Jul; 58(1):20-5. PubMed ID: 15206988
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers.
Sobue S; Tan K; Shaw L; Layton G; Hust R
Eur J Clin Pharmacol; 2004 Jun; 60(4):247-53. PubMed ID: 15103438
[TBL] [Abstract][Full Text] [Related]
3. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Sobue S; Tan K; Layton G; Leclerc V; Weil A
Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
[TBL] [Abstract][Full Text] [Related]
4. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Sobue S; Tan K; Haug-Pihale G
Br J Clin Pharmacol; 2005 Feb; 59(2):160-6. PubMed ID: 15676037
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of Fosfluconazole after single intravenous bolus injection in healthy male Japanese volunteers.
Sobue S; Sekiguchi K; Shimatani K; Tan K
J Clin Pharmacol; 2004 Mar; 44(3):284-92. PubMed ID: 14973307
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants.
Tanzawa A; Saito J; Shoji K; Kojo Y; Funaki T; Maruyama H; Isayama T; Ito Y; Nakamura H; Yamatani A
Microbiol Spectr; 2022 Apr; 10(2):e0195221. PubMed ID: 35266811
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of fluconazole and fosfluconazole after intraperitoneal administration to peritoneal dialysis rats.
Aoyama T; Ogata K; Shimizu M; Hatta S; Masuhara K; Shima Y; Kimura K; Matsumoto Y
Drug Metab Pharmacokinet; 2005 Dec; 20(6):485-90. PubMed ID: 16415533
[TBL] [Abstract][Full Text] [Related]
8. [Nonclinical studies and clinical studies on fosfluconazole, a triazole antifungal agent (Prodif)].
Kawakami Y; Nagino K; Shinkai K; Sobue S; Abe M; Ishiko J
Nihon Yakurigaku Zasshi; 2004 Jul; 124(1):41-51. PubMed ID: 15226621
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.
Aoyama T; Hirata K; Hirata R; Yamazaki H; Yamamoto Y; Hayashi H; Matsumoto Y
J Clin Pharm Ther; 2012 Jun; 37(3):356-63. PubMed ID: 21883330
[TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.
Darwish M; Hellriegel ET
Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239
[TBL] [Abstract][Full Text] [Related]
11. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults.
Thompson GR; Lewis P; Mudge S; Patterson TF; Burnett BP
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457106
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses.
Latimer FG; Colitz CM; Campbell NB; Papich MG
Am J Vet Res; 2001 Oct; 62(10):1606-11. PubMed ID: 11592327
[TBL] [Abstract][Full Text] [Related]
13. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
14. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.
Flanagan S; Fang E; Muñoz KA; Minassian SL; Prokocimer PG
Pharmacotherapy; 2014 Sep; 34(9):891-900. PubMed ID: 24989138
[TBL] [Abstract][Full Text] [Related]
15. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
[TBL] [Abstract][Full Text] [Related]
16. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on fluconazole (FLCZ) in the treatment of primary pulmonary cryptococcosis].
Hayashi Y; Ito G; Takeyama S
Kansenshogaku Zasshi; 1998 Dec; 72(12):1261-8. PubMed ID: 9916411
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
[TBL] [Abstract][Full Text] [Related]
19. Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects.
Bond M; Rabinovich-Guilatt L; Selim S; Darwish M; Tracewell W; Robertson P; Yang R; Malamut R; Colucci P; Ducharme MP; Spiegelstein O
Clin Drug Investig; 2017 Dec; 37(12):1153-1163. PubMed ID: 28948482
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
Purkins L; Wood N; Greenhalgh K; Eve MD; Oliver SD; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):2-9. PubMed ID: 14616407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
